PYXS ▼ -0.6% - Pyxis Oncology, Inc.
$PYXS - Pyxis Oncology Reports Third Quarter 2026 Financial Results and Highlights Progress Toward Pivotal Development of Micvotabart Pelidotin (MICVO)
05-NOV-2026 07:00 AM ET
Share this post
More filings for $PYXS
PYXS - Pyxis Oncology, Inc. - SEC Filing Update (03-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 3, 2026PYXS ▲ +0.5% - Pyxis Oncology, Inc.Oct 28, 2026PYXS - Pyxis Oncology, Inc. - SEC Filing Update (09-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 9, 2026PYXS - Pyxis Oncology, Inc. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 5, 2026PYXS - Pyxis Oncology, Inc. - SEC Filing Update (02-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 2, 2026PYXS ▼ -9.3% - Pyxis Oncology, Inc.Sep 30, 2026
View full $PYXS filing history →💬 Comments
Loading comments…
Leave a comment